Baseline cardiopulmonary function as an independent prognostic factor for survival of inoperable non-small-cell lung cancer after concurrent chemoradiotherapy: A single-center analysis of 161 cases

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 1, 2011, Pages 96-104

  Semrau, Sabine ^a,b   Klautke, Gunther ^b   Fietkau, Rainer ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Chemoradiation; Heart function; Non small cell lung cancer; Prognosis; Pulmonary function; Toxicity

Indexed keywords

CHEMORADIATION; HEART FUNCTION; NON SMALL CELL LUNG CANCER; PROGNOSIS; PULMONARY FUNCTION;

CARBON MONOXIDE; HEART; MULTIVARIANT ANALYSIS; TOXICITY;

BIOLOGICAL ORGANS;

CARBON MONOXIDE; CARBOPLATIN; CISPLATIN; IRINOTECAN; NAVELBINE;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOPULMONARY FUNCTION; ESOPHAGITIS; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; LUNG DIFFUSION CAPACITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA; TOXICITY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HEART; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR; KIDNEY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PULMONARY DIFFUSING CAPACITY; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 78650006971     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.10.010     Document Type: Article

References (19)

1. S. Semrau, A. Bier, and U. Thierbach Six-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer Strahlenther Onkol 183 2007 30 35
2. G. Beckmann, R. Fietkau, and R.M. Huber Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): A feasibility study Onkologie 29 2006 137 142
3. S. Semrau, G. Klautke, and R. Fietkau Results of concurrent radiochemotherapy with cisplatin and irinotecan in patients with local advanced non-small cell lung cancer Strahlenther Onkol 183 Suppl 1 2007 99
4. K. Furuse, M. Fukuoka, and M. Kawahara Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
5. P. Zatloukal, L. Petruzelka, and M. Zemanova Concurrent vs. sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study Lung Cancer 46 2004 87 98
6. P. Fournel, G. Robinet, and P. Thomas Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Franais de Pneumo-Cancerologie NPC 95-01 Study J Clin Oncol 23 2005 5910 5917
7. SEER Cancer Statistics Review 1975-2001, Available at: http://seer.cancer.gov/cgi-bin/csr/1975-2005/search, Accessed February 10, 2009
8. R.R. Jennens, G.G. Giles, and R.M. Fox Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials Intern Med J 36 2006 216 220
9. M. Fischer, A. Baessler, and S.R. Holmer Epidemiology of left ventricular systolic dysfunction in the general population of Germany: Results of an echocardiographic study of a large population-based sample Z Kardiol 92 2003 294 302
10. D. De Ruysscher, A. Botterweck, and M. Dirx Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: A prospective, population-based study Ann Oncol 20 2009 98 102
11. J. Foeglé, G. Hédelin, M.P. Lebetasy, A. Purohit, M. Velten, and E. Quoix Non-small-cell lung cancer in a French department (1982-1997): Management and outcome Br J Cancer 92 2005 459 466
12. S. Firat, R.W. Byhardt, and E. Gore Comorbidity and Karnofsky performance score are independent prognostic factors in stage III non-small-cell lung cancer: An institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 54 2002 357 364
13. S. Firat, A. Pleister, R.W. Byhardt, and E. Gore Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III non-small-cell lung cancer (NSCLC) Am J Clin Oncol 29 2006 252 257
14. F. Bursi, S.A. Weston, and M.M. Redfield Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
15. M. Pelkonen, I.L. Notkola, and A. Nissinen Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: A follow-up in middle-aged rural men Chest 130 2006 1129 1137
16. S. Ishikura, K. Nihei, and A. Ohtsu Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus J Clin Oncol 21 2003 2697 2702 (Pubitemid 46606313)
17. J.G. Reinders, B.J. Heijmen, and M.J. Olofsen-van Acht Ischemic heart disease after mantle field irradiation for Hodgkin's disease in long-term follow-up Radiother Oncol 51 1999 35 42
18. S.C. Darby, P. McGale, and C.W. Taylor Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries Lancet Oncol 6 2005 557 565
19. L. Guldner, N. Haddy, and F. Pein Radiation dose and long-term risk of cardiac pathology following radiotherapy and anthracyclin for childhood cancer Radiother Oncol 81 2006 47 56